U.K.Pathak M.D., PA

U.K.Pathak M.D., PA was paid $10.32M by Medicaid between Jan 2018 and Dec 2024, across 80 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.

33Billing provider infoU.K.PATHAK M.D., PA
WESLACO, TX 78596

33aNPI1639504996assigned 09/05/2013

33bProvider typePediatrics Physician

28Total paid$10.32M

24GClaims491,341

24DCodes billed80

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Pediatrics Physician providers in Texas

Rank by total paid#22 of 1,136

Median peer was paid$329K

This provider vs. median31×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	732	$19K
2019	1,182	$28K
2020	27,626	$583K
2021	106,530	$2.19M
2022	139,676	$2.93M
2023	116,125	$2.46M
2024incomplete	99,470	$2.11M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	29%	85,754	73,438	$3.03M
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	17%	44,786	40,211	$1.76M
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	9.2%	70,836	32,258	$949K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	5.4%	7,008	6,826	$559K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	5.2%	39,678	36,406	$534K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	4.7%	6,452	6,193	$483K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	4.3%	5,501	5,256	$449K
S8301	Infection control supplies, not otherwise specified	3.7%	53,737	46,340	$385K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	2.8%	3,936	3,712	$289K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	2.8%	5,476	5,228	$284K
90460	Immunization administration through 18 years of age via any route, first or only component	2.6%	26,029	12,994	$273K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	2.5%	5,918	5,420	$254K

68 more codes

85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.1%	34,118	$218K
99429		1.6%	5,090	$163K
99203	Doctor's office visit, new patient (routine)	<1%	1,602	$93K
87807		<1%	7,429	$79K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	170	$65K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	6,796	$53K
92567		<1%	3,487	$43K
87428		<1%	754	$39K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	419	$34K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	1,267	$29K
90461		<1%	3,732	$25K
0002A		<1%	625	$24K
71046	Radiologic examination, chest; 2 views	<1%	843	$22K
99051		<1%	5,418	$22K
94010		<1%	908	$21K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	1,331	$19K
92587		<1%	952	$12K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	295	$12K
0071A		<1%	292	$12K
CP002		<1%	1,096	$11K
96161		<1%	5,858	$10K
0072A		<1%	234	$9K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	302	$9K
87486		<1%	170	$5K
87581		<1%	169	$5K
G8510	Screening for depression is documented as negative, a follow-up plan is not required	<1%	483	$5K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	65	$5K
97169		<1%	195	$4K
99050		<1%	326	$4K
81005		<1%	1,952	$3K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	98	$3K
83655		<1%	266	$3K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	149	$2K
70220		<1%	68	$2K
74018		<1%	71	$2K
0003A		<1%	34	$1K
99222	Initial hospital care, per day, moderate complexity	<1%	12	$1K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	87	$1K
0081A		<1%	21	$840.00
86580		<1%	93	$737.14
90686		<1%	4,859	$556.62
97802		<1%	13,601	$330.07
92551		<1%	64	$326.76
74019		<1%	12	$316.56
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	33	$303.18
90671		<1%	1,289	$171.00
90619		<1%	726	$152.00
90651		<1%	954	$75.00
90656		<1%	763	$70.88
90620		<1%	693	$62.00
90734		<1%	258	$2.00
96160		<1%	3,779	$2.00
90715		<1%	264	$1.00
S9451	Exercise classes, non-physician provider, per session	<1%	13,602	$1.00
90680		<1%	1,179	$0.01
90648		0%	584	$0.00
90710		0%	866	$0.00
90670		0%	1,511	$0.00
90633		0%	914	$0.00
90700		0%	41	$0.00
91300		0%	752	$0.00
91308		0%	29	$0.00
90697		0%	1,062	$0.00
90723		0%	214	$0.00
90696		0%	234	$0.00
91307		0%	585	$0.00
90698		0%	72	$0.00
J0696	Injection, ceftriaxone sodium, per 250 mg	0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPATHAK, UMESH (PRESIDENT)